Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 295 entries
Sorted by: Best Match Show Resources per page
The effect of spinal cord stimulation on pain medication reduction in intractable spine and limb pain: a systematic review of randomized controlled trials and meta-analysis.

Journal of pain research

Pollard EM, Lamer TJ, Moeschler SM, Gazelka HM, Hooten WM, Bendel MA, Warner NS, Murad MH.
PMID: 31118751
J Pain Res. 2019 Apr 30;12:1311-1324. doi: 10.2147/JPR.S186662. eCollection 2019.

No abstract available.

Cite
Pollard EM, Lamer TJ, Moeschler SM, et al. The effect of spinal cord stimulation on pain medication reduction in intractable spine and limb pain: a systematic review of randomized controlled trials and meta-analysis. J Pain Res. 2019;12:1311-1324doi: 10.2147/JPR.S186662.
Pollard, E. M., Lamer, T. J., Moeschler, S. M., Gazelka, H. M., Hooten, W. M., Bendel, M. A., Warner, N. S., & Murad, M. H. (2019). The effect of spinal cord stimulation on pain medication reduction in intractable spine and limb pain: a systematic review of randomized controlled trials and meta-analysis. Journal of pain research, 121311-1324. https://doi.org/10.2147/JPR.S186662
Pollard, E Morgan, et al. "The effect of spinal cord stimulation on pain medication reduction in intractable spine and limb pain: a systematic review of randomized controlled trials and meta-analysis." Journal of pain research vol. 12 (2019): 1311-1324. doi: https://doi.org/10.2147/JPR.S186662
Pollard EM, Lamer TJ, Moeschler SM, Gazelka HM, Hooten WM, Bendel MA, Warner NS, Murad MH. The effect of spinal cord stimulation on pain medication reduction in intractable spine and limb pain: a systematic review of randomized controlled trials and meta-analysis. J Pain Res. 2019 Apr 30;12:1311-1324. doi: 10.2147/JPR.S186662. eCollection 2019. PMID: 31118751; PMCID: PMC6502439.
Copy Download .nbib Format: NLM
Restructuring of a General Surgery Residency Program in an Epicenter of the Coronavirus Disease 2019 Pandemic: Lessons From New York City.

JAMA surgery

Juprasert JM, Gray KD, Moore MD, Obeid L, Peters AW, Fehling D, Fahey TJ, Yeo HL.
PMID: 32633754
JAMA Surg. 2020 Jul 07; doi: 10.1001/jamasurg.2020.3107. Epub 2020 Jul 07.

On March 1, 2020, the first case of coronavirus disease 2019 (COVID-19) was confirmed in New York, New York. Since then, the city has emerged as an epicenter for the ongoing pandemic in the US. To meet the anticipated...

Cite
Juprasert JM, Gray KD, Moore MD, et al. Restructuring of a General Surgery Residency Program in an Epicenter of the Coronavirus Disease 2019 Pandemic: Lessons From New York City. JAMA Surg. 2020;doi: 10.1001/jamasurg.2020.3107.
Juprasert, J. M., Gray, K. D., Moore, M. D., Obeid, L., Peters, A. W., Fehling, D., Fahey, T. J., & Yeo, H. L. (2020). Restructuring of a General Surgery Residency Program in an Epicenter of the Coronavirus Disease 2019 Pandemic: Lessons From New York City. JAMA surgery, . https://doi.org/10.1001/jamasurg.2020.3107
Juprasert, Jackly M, et al. "Restructuring of a General Surgery Residency Program in an Epicenter of the Coronavirus Disease 2019 Pandemic: Lessons From New York City." JAMA surgery vol. (2020). doi: https://doi.org/10.1001/jamasurg.2020.3107
Juprasert JM, Gray KD, Moore MD, Obeid L, Peters AW, Fehling D, Fahey TJ, Yeo HL. Restructuring of a General Surgery Residency Program in an Epicenter of the Coronavirus Disease 2019 Pandemic: Lessons From New York City. JAMA Surg. 2020 Jul 07; doi: 10.1001/jamasurg.2020.3107. Epub 2020 Jul 07. PMID: 32633754.
Copy Download .nbib Format: NLM
Smoking cessation patterns by socioeconomic status in Alaska.

Preventive medicine reports

Pizacani B, Pickle K, Maher J, Rohde K, Fenaughty A.
PMID: 29868355
Prev Med Rep. 2018 Feb 09;10:24-28. doi: 10.1016/j.pmedr.2018.01.007. eCollection 2018 Jun.

The ongoing disparity in smoking prevalence across levels of socioeconomic status (SES) is a significant concern in the tobacco control field, and surveillance of cessation-related activity is key to understanding progress. Historically, lower SES smokers have had much lower...

Cite
Pizacani B, Pickle K, Maher J, et al. Smoking cessation patterns by socioeconomic status in Alaska. Prev Med Rep. 2018;10:24-28doi: 10.1016/j.pmedr.2018.01.007.
Pizacani, B., Pickle, K., Maher, J., Rohde, K., & Fenaughty, A. (2018). Smoking cessation patterns by socioeconomic status in Alaska. Preventive medicine reports, 1024-28. https://doi.org/10.1016/j.pmedr.2018.01.007
Pizacani, Barbara, et al. "Smoking cessation patterns by socioeconomic status in Alaska." Preventive medicine reports vol. 10 (2018): 24-28. doi: https://doi.org/10.1016/j.pmedr.2018.01.007
Pizacani B, Pickle K, Maher J, Rohde K, Fenaughty A. Smoking cessation patterns by socioeconomic status in Alaska. Prev Med Rep. 2018 Feb 09;10:24-28. doi: 10.1016/j.pmedr.2018.01.007. eCollection 2018 Jun. PMID: 29868355; PMCID: PMC5984207.
Copy Download .nbib Format: NLM
Target dependence of central rapidity Lambda production in sulfur-nucleus collisions at 200 GeV/c per nucleon.

Physical review. C, Nuclear physics

Andersen E, Barnes PD, Blaes R, Braun H, Brom JM, Castaño B, Cherney M, Cohler M, de la Cruz B, Diebold GE, Fernández C, Franklin G, Garabatos C, Garzón JA, Geist WM, Greiner D, Gruhn C, Hafidouni M, Hrubec J, Huss D, Jacquot JL, Jones PG, Kuipers JP, Ladrem M, Ladrón de Guevara P, Liko D, Lopez-Ponte S, Lovhoiden G, MacNaughton J, Maher CJ, Michalon A, Michalon-Mentzer ME, Mosquera J, Natkaniec Z, Nelson JM, Neuhofer G, Perez de los Heros C, Pló M, Porth P, Powell B, Quinn B, Ramil A, Riester JL, Rohringer H, Sakrejda G, Sakrejda I, Thorsteinsen T, Traxler J, Voltolini C, Yañez A, Yepes P, Zybert R.
PMID: 9968170
Phys Rev C Nucl Phys. 1992 Aug;46(2):727-735. doi: 10.1103/physrevc.46.727.

No abstract available.

Cite
Andersen E, Barnes PD, Blaes R, et al. Target dependence of central rapidity Lambda production in sulfur-nucleus collisions at 200 GeV/c per nucleon. Phys Rev C Nucl Phys. 1992;46(2):727-735doi: 10.1103/physrevc.46.727.
Andersen, E., Barnes, P. D., Blaes, R., Braun, H., Brom, J. M., Castaño, B., Cherney, M., Cohler, M., de la Cruz B, Diebold, G. E., Fernández, C., Franklin, G., Garabatos, C., Garzón, J. A., Geist, W. M., Greiner, D., Gruhn, C., Hafidouni, M., Hrubec, J., Huss, D., Jacquot, J. L., Jones, P. G., Kuipers, J. P., Ladrem, M., Ladrón de Guevara P, Liko, D., Lopez-Ponte, S., Lovhoiden, G., MacNaughton, J., Maher, C. J., Michalon, A., Michalon-Mentzer, M. E., Mosquera, J., Natkaniec, Z., Nelson, J. M., Neuhofer, G., Perez de los Heros C, Pló, M., Porth, P., Powell, B., Quinn, B., Ramil, A., Riester, J. L., Rohringer, H., Sakrejda, G., Sakrejda, I., Thorsteinsen, T., Traxler, J., Voltolini, C., Yañez, A., Yepes, P., & Zybert, R. (1992). Target dependence of central rapidity Lambda production in sulfur-nucleus collisions at 200 GeV/c per nucleon. Physical review. C, Nuclear physics, 46(2), 727-735. https://doi.org/10.1103/physrevc.46.727
Andersen, et al. "Target dependence of central rapidity Lambda production in sulfur-nucleus collisions at 200 GeV/c per nucleon." Physical review. C, Nuclear physics vol. 46,2 (1992): 727-735. doi: https://doi.org/10.1103/physrevc.46.727
Andersen E, Barnes PD, Blaes R, Braun H, Brom JM, Castaño B, Cherney M, Cohler M, de la Cruz B, Diebold GE, Fernández C, Franklin G, Garabatos C, Garzón JA, Geist WM, Greiner D, Gruhn C, Hafidouni M, Hrubec J, Huss D, Jacquot JL, Jones PG, Kuipers JP, Ladrem M, Ladrón de Guevara P, Liko D, Lopez-Ponte S, Lovhoiden G, MacNaughton J, Maher CJ, Michalon A, Michalon-Mentzer ME, Mosquera J, Natkaniec Z, Nelson JM, Neuhofer G, Perez de los Heros C, Pló M, Porth P, Powell B, Quinn B, Ramil A, Riester JL, Rohringer H, Sakrejda G, Sakrejda I, Thorsteinsen T, Traxler J, Voltolini C, Yañez A, Yepes P, Zybert R. Target dependence of central rapidity Lambda production in sulfur-nucleus collisions at 200 GeV/c per nucleon. Phys Rev C Nucl Phys. 1992 Aug;46(2):727-735. doi: 10.1103/physrevc.46.727. PMID: 9968170.
Copy Download .nbib Format: NLM
Reply.

Arthritis & rheumatology (Hoboken, N.J.)

Maher TM, Mayes MD, Stock C, Alves M.
PMID: 34105317
Arthritis Rheumatol. 2021 Dec;73(12):2354-2355. doi: 10.1002/art.41895. Epub 2021 Oct 19.

No abstract available.

Cite
Maher TM, Mayes MD, Stock C, et al. Reply. Arthritis Rheumatol. 2021;73(12):2354-2355doi: 10.1002/art.41895.
Maher, T. M., Mayes, M. D., Stock, C., & Alves, M. (2021). Reply. Arthritis & rheumatology (Hoboken, N.J.), 73(12), 2354-2355. https://doi.org/10.1002/art.41895
Maher, Toby M, et al. "Reply." Arthritis & rheumatology (Hoboken, N.J.) vol. 73,12 (2021): 2354-2355. doi: https://doi.org/10.1002/art.41895
Maher TM, Mayes MD, Stock C, Alves M. Reply. Arthritis Rheumatol. 2021 Dec;73(12):2354-2355. doi: 10.1002/art.41895. Epub 2021 Oct 19. PMID: 34105317.
Copy Download .nbib Format: NLM
Dysregulation of Streptococcus pneumoniae zinc homeostasis breaks ampicillin resistance in a pneumonia infection model.

Cell reports

Brazel EB, Tan A, Neville SL, Iverson AR, Udagedara SR, Cunningham BA, Sikanyika M, De Oliveira DMP, Keller B, Bohlmann L, El-Deeb IM, Ganio K, Eijkelkamp BA, McEwan AG, von Itzstein M, Maher MJ, Walker MJ, Rosch JW, McDevitt CA.
PMID: 35021083
Cell Rep. 2022 Jan 11;38(2):110202. doi: 10.1016/j.celrep.2021.110202.

Streptococcus pneumoniae is the primary cause of community-acquired bacterial pneumonia with rates of penicillin and multidrug-resistance exceeding 80% and 40%, respectively. The innate immune response generates a variety of antimicrobial agents to control infection, including zinc stress. Here, we...

Cite
Brazel EB, Tan A, Neville SL, et al. Dysregulation of Streptococcus pneumoniae zinc homeostasis breaks ampicillin resistance in a pneumonia infection model. Cell Rep. 2022;38(2):110202doi: 10.1016/j.celrep.2021.110202.
Brazel, E. B., Tan, A., Neville, S. L., Iverson, A. R., Udagedara, S. R., Cunningham, B. A., Sikanyika, M., De Oliveira, D. M. P., Keller, B., Bohlmann, L., El-Deeb, I. M., Ganio, K., Eijkelkamp, B. A., McEwan, A. G., von Itzstein, M., Maher, M. J., Walker, M. J., Rosch, J. W., & McDevitt, C. A. (2022). Dysregulation of Streptococcus pneumoniae zinc homeostasis breaks ampicillin resistance in a pneumonia infection model. Cell reports, 38(2), 110202. https://doi.org/10.1016/j.celrep.2021.110202
Brazel, Erin B, et al. "Dysregulation of Streptococcus pneumoniae zinc homeostasis breaks ampicillin resistance in a pneumonia infection model." Cell reports vol. 38,2 (2022): 110202. doi: https://doi.org/10.1016/j.celrep.2021.110202
Brazel EB, Tan A, Neville SL, Iverson AR, Udagedara SR, Cunningham BA, Sikanyika M, De Oliveira DMP, Keller B, Bohlmann L, El-Deeb IM, Ganio K, Eijkelkamp BA, McEwan AG, von Itzstein M, Maher MJ, Walker MJ, Rosch JW, McDevitt CA. Dysregulation of Streptococcus pneumoniae zinc homeostasis breaks ampicillin resistance in a pneumonia infection model. Cell Rep. 2022 Jan 11;38(2):110202. doi: 10.1016/j.celrep.2021.110202. PMID: 35021083.
Copy Download .nbib Format: NLM
(E)-2,3-Bis[(E)-benzyl-idene-amino]-but-2-enedinitrile.

Acta crystallographica. Section E, Structure reports online

Akerman MP, Maher SJ.
PMID: 22412581
Acta Crystallogr Sect E Struct Rep Online. 2012 Mar 01;68:o688. doi: 10.1107/S1600536812005363. Epub 2012 Feb 10.

The asymmetric unit of the title compound, C(18)H(12)N(4), consists of a half-mol-ecule, where the two halves of the mol-ecule are related by inversion symmetry. The mol-ecule is effectively planar, with the largest deviation from the 22-atom mean plane, measuring...

Cite
Akerman MP, Maher SJ. (E)-2,3-Bis[(E)-benzyl-idene-amino]-but-2-enedinitrile. Acta Crystallogr Sect E Struct Rep Online. 2012;68:o688doi: 10.1107/S1600536812005363.
Akerman, M. P., & Maher, S. J. (2012). (E)-2,3-Bis[(E)-benzyl-idene-amino]-but-2-enedinitrile. Acta crystallographica. Section E, Structure reports online, 68o688. https://doi.org/10.1107/S1600536812005363
Akerman, Matthew P, and Maher, Sarah J. "(E)-2,3-Bis[(E)-benzyl-idene-amino]-but-2-enedinitrile." Acta crystallographica. Section E, Structure reports online vol. 68 (2012): o688. doi: https://doi.org/10.1107/S1600536812005363
Akerman MP, Maher SJ. (E)-2,3-Bis[(E)-benzyl-idene-amino]-but-2-enedinitrile. Acta Crystallogr Sect E Struct Rep Online. 2012 Mar 01;68:o688. doi: 10.1107/S1600536812005363. Epub 2012 Feb 10. PMID: 22412581; PMCID: PMC3295470.
Copy Download .nbib Format: NLM
Effect of high-intensity interval training on cardiometabolic component risks in persons with paraplegia: Protocol for a randomized controlled trial.

Experimental physiology

Farrow MT, Maher J, Thompson D, Bilzon JLJ.
PMID: 33600014
Exp Physiol. 2021 May;106(5):1159-1165. doi: 10.1113/EP089110. Epub 2021 Mar 20.

Individuals with a spinal cord injury (SCI) are at an increased risk of developing cardiovascular disease and present with a multitude of elevated cardiometabolic component risks. Although upper-body exercise appears an effective strategy to improve some of these outcomes,...

Cite
Farrow MT, Maher J, Thompson D, et al. Effect of high-intensity interval training on cardiometabolic component risks in persons with paraplegia: Protocol for a randomized controlled trial. Exp Physiol. 2021;106(5):1159-1165doi: 10.1113/EP089110.
Farrow, M. T., Maher, J., Thompson, D., & Bilzon, J. L. J. (2021). Effect of high-intensity interval training on cardiometabolic component risks in persons with paraplegia: Protocol for a randomized controlled trial. Experimental physiology, 106(5), 1159-1165. https://doi.org/10.1113/EP089110
Farrow, Matthew T, et al. "Effect of high-intensity interval training on cardiometabolic component risks in persons with paraplegia: Protocol for a randomized controlled trial." Experimental physiology vol. 106,5 (2021): 1159-1165. doi: https://doi.org/10.1113/EP089110
Farrow MT, Maher J, Thompson D, Bilzon JLJ. Effect of high-intensity interval training on cardiometabolic component risks in persons with paraplegia: Protocol for a randomized controlled trial. Exp Physiol. 2021 May;106(5):1159-1165. doi: 10.1113/EP089110. Epub 2021 Mar 20. PMID: 33600014.
Copy Download .nbib Format: NLM
The structural basis of bacterial manganese import.

Science advances

Neville SL, Sjöhamn J, Watts JA, MacDermott-Opeskin H, Fairweather SJ, Ganio K, Carey Hulyer A, McGrath AP, Hayes AJ, Malcolm TR, Davies MR, Nomura N, Iwata S, O'Mara ML, Maher MJ, McDevitt CA.
PMID: 34362732
Sci Adv. 2021 Aug 06;7(32). doi: 10.1126/sciadv.abg3980. Print 2021 Aug.

Metal ions are essential for all forms of life. In prokaryotes, ATP-binding cassette (ABC) permeases serve as the primary import pathway for many micronutrients including the first-row transition metal manganese. However, the structural features of ionic metal transporting ABC...

Cite
Neville SL, Sjöhamn J, Watts JA, et al. The structural basis of bacterial manganese import. Sci Adv. 2021;7(32)doi: 10.1126/sciadv.abg3980.
Neville, S. L., Sjöhamn, J., Watts, J. A., MacDermott-Opeskin, H., Fairweather, S. J., Ganio, K., Carey Hulyer, A., McGrath, A. P., Hayes, A. J., Malcolm, T. R., Davies, M. R., Nomura, N., Iwata, S., O'Mara, M. L., Maher, M. J., & McDevitt, C. A. (2021). The structural basis of bacterial manganese import. Science advances, 7(32), . https://doi.org/10.1126/sciadv.abg3980
Neville, Stephanie L, et al. "The structural basis of bacterial manganese import." Science advances vol. 7,32 (2021). doi: https://doi.org/10.1126/sciadv.abg3980
Neville SL, Sjöhamn J, Watts JA, MacDermott-Opeskin H, Fairweather SJ, Ganio K, Carey Hulyer A, McGrath AP, Hayes AJ, Malcolm TR, Davies MR, Nomura N, Iwata S, O'Mara ML, Maher MJ, McDevitt CA. The structural basis of bacterial manganese import. Sci Adv. 2021 Aug 06;7(32). doi: 10.1126/sciadv.abg3980. Print 2021 Aug. PMID: 34362732; PMCID: PMC8346216.
Copy Download .nbib Format: NLM
Synergistic T cell signaling by 41BB and CD28 is optimally achieved by membrane proximal positioning within parallel chimeric antigen receptors.

Cell reports. Medicine

Muliaditan T, Halim L, Whilding LM, Draper B, Achkova DY, Kausar F, Glover M, Bechman N, Arulappu A, Sanchez J, Flaherty KR, Obajdin J, Grigoriadis K, Antoine P, Larcombe-Young D, Hull CM, Buus R, Gordon P, Grigoriadis A, Davies DM, Schurich A, Maher J.
PMID: 35028604
Cell Rep Med. 2021 Dec 21;2(12):100457. doi: 10.1016/j.xcrm.2021.100457. eCollection 2021 Dec 21.

Second generation (2G) chimeric antigen receptors (CARs) contain a CD28 or 41BB co-stimulatory endodomain and elicit remarkable efficacy in hematological malignancies. Third generation (3G) CARs extend this linear blueprint by fusing both co-stimulatory units in series. However, clinical impact...

Cite
Muliaditan T, Halim L, Whilding LM, et al. Synergistic T cell signaling by 41BB and CD28 is optimally achieved by membrane proximal positioning within parallel chimeric antigen receptors. Cell Rep Med. 2021;2(12):100457doi: 10.1016/j.xcrm.2021.100457.
Muliaditan, T., Halim, L., Whilding, L. M., Draper, B., Achkova, D. Y., Kausar, F., Glover, M., Bechman, N., Arulappu, A., Sanchez, J., Flaherty, K. R., Obajdin, J., Grigoriadis, K., Antoine, P., Larcombe-Young, D., Hull, C. M., Buus, R., Gordon, P., Grigoriadis, A., Davies, D. M., Schurich, A., & Maher, J. (2021). Synergistic T cell signaling by 41BB and CD28 is optimally achieved by membrane proximal positioning within parallel chimeric antigen receptors. Cell reports. Medicine, 2(12), 100457. https://doi.org/10.1016/j.xcrm.2021.100457
Muliaditan, Tamara, et al. "Synergistic T cell signaling by 41BB and CD28 is optimally achieved by membrane proximal positioning within parallel chimeric antigen receptors." Cell reports. Medicine vol. 2,12 (2021): 100457. doi: https://doi.org/10.1016/j.xcrm.2021.100457
Muliaditan T, Halim L, Whilding LM, Draper B, Achkova DY, Kausar F, Glover M, Bechman N, Arulappu A, Sanchez J, Flaherty KR, Obajdin J, Grigoriadis K, Antoine P, Larcombe-Young D, Hull CM, Buus R, Gordon P, Grigoriadis A, Davies DM, Schurich A, Maher J. Synergistic T cell signaling by 41BB and CD28 is optimally achieved by membrane proximal positioning within parallel chimeric antigen receptors. Cell Rep Med. 2021 Dec 21;2(12):100457. doi: 10.1016/j.xcrm.2021.100457. eCollection 2021 Dec 21. PMID: 35028604; PMCID: PMC8714859.
Copy Download .nbib Format: NLM
The use of the Hospital Anxiety and Depression Scale (HADS) and the EORTC QLQ-C30 questionnaires to screen for treatable unmet needs in patients attending routinely for radiotherapy.

Cancer treatment reviews

Maher EJ, Mackenzie C, Young T, Marks D.
PMID: 8625337
Cancer Treat Rev. 1996 Jan;22:123-9. doi: 10.1016/s0305-7372(96)90074-2.

No abstract available.

Cite
Maher EJ, Mackenzie C, Young T, et al. The use of the Hospital Anxiety and Depression Scale (HADS) and the EORTC QLQ-C30 questionnaires to screen for treatable unmet needs in patients attending routinely for radiotherapy. Cancer Treat Rev. 1996;22:123-9doi: 10.1016/s0305-7372(96)90074-2.
Maher, E. J., Mackenzie, C., Young, T., & Marks, D. (1996). The use of the Hospital Anxiety and Depression Scale (HADS) and the EORTC QLQ-C30 questionnaires to screen for treatable unmet needs in patients attending routinely for radiotherapy. Cancer treatment reviews, 22123-9. https://doi.org/10.1016/s0305-7372(96)90074-2
Maher, E J, et al. "The use of the Hospital Anxiety and Depression Scale (HADS) and the EORTC QLQ-C30 questionnaires to screen for treatable unmet needs in patients attending routinely for radiotherapy." Cancer treatment reviews vol. 22 (1996): 123-9. doi: https://doi.org/10.1016/s0305-7372(96)90074-2
Maher EJ, Mackenzie C, Young T, Marks D. The use of the Hospital Anxiety and Depression Scale (HADS) and the EORTC QLQ-C30 questionnaires to screen for treatable unmet needs in patients attending routinely for radiotherapy. Cancer Treat Rev. 1996 Jan;22:123-9. doi: 10.1016/s0305-7372(96)90074-2. PMID: 8625337.
Copy Download .nbib Format: NLM
Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Scheiblauer H, Nübling CM, Wolf T, Khodamoradi Y, Bellinghausen C, Sonntagbauer M, Esser-Nobis K, Filomena A, Mahler V, Maier TJ, Stephan C.
PMID: 34920374
J Clin Virol. 2021 Dec 04;146:105052. doi: 10.1016/j.jcv.2021.105052. Epub 2021 Dec 04.

BACKGROUND: Antibody detection of SARS-CoV-2 requires an understanding of its variation, course, and duration.METHODS: Antibody response to SARS-CoV-2 was evaluated over 5-430 days on 828 samples across COVID-19 severity levels, for total antibody (TAb), IgG, IgA, IgM, neutralizing antibody...

Cite
Scheiblauer H, Nübling CM, Wolf T, et al. Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design. J Clin Virol. 2021;146:105052doi: 10.1016/j.jcv.2021.105052.
Scheiblauer, H., Nübling, C. M., Wolf, T., Khodamoradi, Y., Bellinghausen, C., Sonntagbauer, M., Esser-Nobis, K., Filomena, A., Mahler, V., Maier, T. J., & Stephan, C. (2021). Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 146105052. https://doi.org/10.1016/j.jcv.2021.105052
Scheiblauer, Heinrich, et al. "Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design." Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology vol. 146 (2021): 105052. doi: https://doi.org/10.1016/j.jcv.2021.105052
Scheiblauer H, Nübling CM, Wolf T, Khodamoradi Y, Bellinghausen C, Sonntagbauer M, Esser-Nobis K, Filomena A, Mahler V, Maier TJ, Stephan C. Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design. J Clin Virol. 2021 Dec 04;146:105052. doi: 10.1016/j.jcv.2021.105052. Epub 2021 Dec 04. PMID: 34920374; PMCID: PMC8642248.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 295 entries